The North America direct-to-consumer genetic testing market size was estimated at USD 1.20 billion in 2025 and is projected to be worth around USD 9.13 billion by 2035, is expanding at a CAGR of 22.50% from 2026 to 2035. The market is mainly fueled by growing consumer interest in personalized health and ancestry, increased disposable incomes, and the necessity for early risk evaluation of chronic diseases.

North America Direct-to-Consumer Genetic Testing Market Statical Scope

The North America direct-to-consumer (DTC) genetic testing market is important because it gives consumers direct access to health, ancestry, and lifestyle information, speeding up the move towards personalized medicine . It plays a key role in promoting proactive preventive healthcare, enabling individuals to evaluate disease risks and make, as it puts it, proactive lifestyle changes.

The market employs advanced methods like SNP genotyping and whole-genome sequencing, with improvements in AI-driven genetic analysis boosting accuracy and lowering test costs. The high demand for genealogy services allows consumers to trace their heritage, while health tests offer information on carrier status for inherited diseases.

North America Direct-To-Consumer Genetic Testing Market, By Test Type, 2025 (%)

• Nutrigenomics Testing - The nutrigenomics testing segment plays a key role in the market, driving growth through personalized wellness, driven by strong interest in customized nutrition. This test, which examines the link between genetics and nutrition, holds a 25% market share and is used to determine how a person's genes influence their reaction to nutrients and eating habits.
• Predictive Testing - The predictive testing segment is essential to the market because it enables consumers to assess their risk of diseases such as cancer, heart conditions, and neurodegenerative disorders. This type of testing, which forecasts an individual's likelihood of developing specific genetic disorders or conditions, leads the market with a 40% share, fueled by consumer interest in personalized health information and prevention strategies.

North America Direct-To-Consumer Genetic Testing Market, By Technology, 2025 (%)

• Whole Genome Sequencing - The Whole Genome Sequencing (WGS) segment is crucial to the market, as it analyzes the complete genome for in-depth, actionable health insights, rather than just a few variants. This comprehensive genetic analysis method, which sequences an individual's entire genome, commands a 45% market share due to its capacity to deliver the most thorough genetic data.
• Single Nucleotide Polymorphism Chips - The Single Nucleotide Polymorphism (SNP) chip segment is important in the market because it offers a cost-effective, quick, and precise approach for high-throughput genotyping. This technology, which identifies single-nucleotide variations in a genome, holds a 30% market share and is widely used for genetic screening and research.

North America Direct-To-Consumer Genetic Testing Market, By Distributional Channel, 2025 (%)

• Online Platform - The online platform segment leads the Market. It allows people to easily buy, receive, and analyze genetic information for health and ancestry at home, thereby promoting widespread use. Distribution through websites or mobile app accounts for 70% of the market, driven by the growing demand for at-home testing options and easy online access.
• OTC (Over-the-Counter) - The Over-the-Counter (OTC) segment is crucial for the North American market. It provides immediate access and instant product availability in retail locations like pharmacies and supermarkets, serving as a reliable point for first-time users. Testing available in retail stores for direct consumer purchase accounts for a 30% share, offering convenience compared to online platforms.

Recent Developments in the Market

• In May 2025, Hydreight Technologies Inc., a platform that provides compliant mobile and telehealth services throughout all 50 U.S. states, is announcing the launch of a new direct-to-consumer genetic testing and personalized wellness solution through its VSDHOne platform. This new service allows patients to conveniently obtain at-home DNA testing kits and receive tailored health plans based on their individual genetic profiles.

Competitive Landscape

North America leads the global Direct-to-Consumer (DTC) genetic testing market. This market is very competitive, fueled by increasing health awareness, and is projected to grow significantly due to the high demand for personalized health and ancestry information. Major companies in this space include 23andMe, AncestryDNA, and MyHeritage, which have a strong presence due to their large databases. Color Genomics, Helix OpCo LLC, and FamilyTreeDNA are also making progress, along with smaller companies that focus on wellness. The main factors driving this market are high disposable income, strong consumer awareness, and advancements in AI and genetic screening.

Segments Covered in the Report

By Test Type

• Nutrigenomics Testing
• Predictive Testing
• Carrier Testing
• Others

By Technology

• Whole Genome Sequencing
• Single Nucleotide Polymorphism Chips
• Targeted Analysis
• Others

By Distribution Channel

• Online Platform
• OTC